Gardiner Harris on Johnson & Johnson's Controversies and Dark History

The Dark Secrets of Johnson & Johnson

• 💡 Author Gardiner Harris, former NYT reporter, details Johnson & Johnson's history of fraud in his book, "No More Tears."
• 🎯 J&J is contrasted with companies like Enron and WorldCom, with Harris estimating the company is responsible for roughly 2 million deaths.
• 🔑 A key takeaway is how J&J's mission statement, the Kredo, may have obscured deeply problematic corporate behavior.

Corporate Fraud and Accountability

• ⚖️ While executives in other major fraud cases went to jail, Harris notes that J&J pleaded guilty to criminal charges, but individual executives were rarely prosecuted.
• 📈 Grand jury files obtained by Harris suggest prosecutors found it too difficult to prosecute individual executives.
• ⚠️ J&J is accused of knowingly selling products that not only didn't help but actively harmed and killed people, including targeting babies.

Opioid Crisis and Cancer Drugs

• 💊 Regarding the opioid crisis, Harris states that J&J products were found in 60% of morgue bodies during the prescription opioid crisis, compared to 20% for Purdue Pharma.
• 🔬 J&J sold a popular cancer drug in the 90s and 2000s that Harris estimates cost 500,000 lives.

Talc Controversies and Asbestos Contamination

• 👶 J&J knowingly sold Johnson's baby powder contaminated with asbestos for decades, despite knowing the risks.
• 🔬 The FDA commissioner recently declared talc a carcinogen, largely due to the inability to remove asbestos contamination.
• ⚠️ Talc and asbestos are chemically similar, and it's nearly impossible to mine talc without some asbestos contamination.
• 🚫 Despite other companies transitioning away from talc in the 70s and 80s, J&J stubbornly continued to use it.

Questionable Drug Practices

• 💔 A heartburn drug called Propuls, tested in 20 trials on babies, showed no benefit but was marketed quietly, leading to heart arrhythmias and infant deaths.
• ⚠️ Harris repeatedly emphasizes that J&J knowingly sold products that offered no patient benefit but carried significant risks.